Cerenome, Inc. (CNSY) Stock Forecast
CNSY analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.75 / 5 from 4 analysts
- Price target
- $27.75 average of analyst targets
- Upside to target
- +1,532.4% from the latest close
- Next earnings
- October 29, 2026 EPS estimate $-0.98
- 52-week range
- $1.56 – $18.00
CNSY analyst ratings
4 analystsNumber of analysts at each rating.
CNSY price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CNSY earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$1.03 | −$1.11 | −$0.98 | −$1.00 | −3.0% | 3 |
| Current fiscal year (2026) | −$4.75 | −$5.11 | −$4.40 | −$7.25 | +34.4% | 2 |
| Next fiscal year (2027) | −$2.48 | −$3.17 | −$1.98 | −$4.75 | +47.7% | 4 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CNSY revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $750,000 | $500,000 | $1.0M | −46.3% | 2 |
| Current fiscal year (2026) | $3.7M | $3.0M | $4.4M | −28.6% | 2 |
| Next fiscal year (2027) | $19.1M | $10.0M | $28.0M | +414.6% | 4 |
CNSY EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CNSY revenue: reported and forecast
CNSY EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.86 | −$0.86 | −$0.89 | −$0.92 | −$1.03 | +19.8% | 0 up · 2 down |
| Current fiscal year (2026) | −$3.92 | −$3.92 | −$5.00 | −$4.70 | −$4.75 | +21.2% | 0 up · 0 down |
| Next fiscal year (2027) | −$2.40 | −$2.40 | −$2.40 | −$2.48 | −$2.48 | +3.8% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CNSY earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CNSY beat in 1 of 5.
What analysts expect from CNSY
4 analysts cover Cerenome; their consensus rating is strong buy (4.75 on a 1–5 scale, where 5 is a strong buy). The average price target is $27.75, 1,532.4% above the latest close of $1.70. Analysts expect earnings of −$4.75 per share for 2026, +34.4% from a year earlier. For 2027 the average estimate is −$2.48 per share on revenue of $19.1 million. Cerenome beat the EPS estimate in 1 of the last 5 quarters.
Related: CNSY income statement, CNSY key metrics, CNSY chart. See the CNSY stock overview for the latest quote and news.
CNSY forecast FAQ
What is Cerenome's price target?
The average analyst price target for Cerenome is $27.75, 1,532.4% above the latest close of $1.70.
Is Cerenome a buy, hold or sell?
Of 4 analysts covering Cerenome, 3 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Cerenome's EPS forecast?
Analysts forecast −$4.75 per share for 2026 (range −$5.11 to −$4.40); for 2027 the estimate is −$2.48.
What is Cerenome's revenue forecast?
The average revenue estimate for 2026 is $3.7 million, growth of −28.6%; for 2027 it is $19.1 million.
When does Cerenome report earnings?
Cerenome is expected to report results for the quarter ending September 30, 2026 on October 29, 2026; the EPS estimate is $-0.98.
Does Cerenome usually beat earnings estimates?
Cerenome reported EPS at or above the analyst estimate in 1 of the last 5 quarters.